In an early work on COVID-19, increased expression of NKG2A on CD8+ T cells and NK cells was registered and considered as a signal of depletion and inhibition of the antiviral immune response [32], which could be associated with the progression of COVID-19 in hypertensive patients [87]. The gene discussed is KLRC1; the disease is COVID-19.